tiprankstipranks
Novo Nordisk (NVO)
NYSE:NVO

Novo Nordisk (NVO) Technical Analysis

4,710 Followers

Technical Sentiment

Overall Consensus
Buy
14Bullish
3Neutral
5Bearish
Technical Analysis Consensus
Neutral
4Bullish
3Neutral
3Bearish
Moving Average Consensus
Strong Buy
10Bullish
0Neutral
2Bearish
Novo Nordisk’s (NVO) Moving Averages Convergence Divergence (MACD) indicator is 1.79, suggesting Novo Nordisk is a Sell.
Novo Nordisk’s (NVO) 20-Day exponential moving average is 129.02, while Novo Nordisk’s (NVO) share price is $131.89, making it a Buy.
Novo Nordisk’s (NVO) 50-Day exponential moving average is 126.33, while Novo Nordisk’s (NVO) share price is $131.89, making it a Buy.

Novo Nordisk (NVO) Pivot Points

May 20, 2024, 03:43 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
131.27
131.87
132.46
133.06
133.65
134.25
134.84
Fibonacci
131.87
132.33
132.61
133.06
133.52
133.80
134.25
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Novo Nordisk (NVO) Moving Averages

May 20, 2024, 03:43 AM
Period
Simple
Exponential
MA5
132.98Sell
132.11Sell
MA10
130.06Buy
130.69Buy
MA20
128.24Buy
129.02Buy
MA50
128.03Buy
126.33Buy
MA100
120.79Buy
120.57Buy
MA200
108.20Buy
108.57Buy
Novo Nordisk’s (NVO) 10-Day exponential moving average is 130.69, while Novo Nordisk’s (NVO) share price is $131.89, making it a Buy.
Novo Nordisk’s (NVO) 100-Day exponential moving average is 120.57, while Novo Nordisk’s (NVO) share price is $131.89, making it a Buy.
Novo Nordisk’s (NVO) stock price is $131.89 and Novo Nordisk’s (NVO) 50-day simple moving average is 128.03, creating a Buy signal.
Novo Nordisk’s (NVO) stock price is $131.89 and Novo Nordisk’s (NVO) 100-day simple moving average is 120.79, creating a Buy signal.
Novo Nordisk’s (NVO) stock price is $131.89 and Novo Nordisk’s (NVO) 200-day simple moving average is 108.20, creating a Buy signal.

Novo Nordisk (NVO) Technical Indicators

May 20, 2024, 03:43 AM
Name
Value
Implied Action
RSI (14)
58.71
Neutral
STOCH (9,6)
83.70
Sell
STOCHRSI (14)
88.20
Sell
MACD (12,26)
1.79
Sell
ADX (14)
17.26
Buy
Williams %R
-21.48
Buy
CCI (14)
92.69
Neutral
ATR (14)
2.64
-
Ultimate Oscillator
60.31
Neutral
ROC
3.95
Buy
Novo Nordisk’s (NVO) Relative Strength Index (RSI) is 58.71, creating a Neutral signal.
Novo Nordisk’s (NVO) Trend Strength Indicator (ADX) is 17.26, creating a Buy signal.
Novo Nordisk’s (NVO) Commodity Channel Index (CCI) is 92.69, creating a Neutral signal.
Novo Nordisk’s (NVO) Price Rate of Change (ROC) is 3.95, creating a Buy signal.

FAQ

Is NVO a Buy, Hold, or Sell?
Based on NVO’s technical indicators, NVO is a Buy.
    What is NVO’s RSI (14)?
    NVO’s RSI (14) is 58.71, which suggests NVO is a Neutral.
      What is NVO’s MACD?
      NVO’s MACD is 1.79, which suggests NVO is a Sell.
        What is NVO’s 5-day moving average?
        NVO’s 5-day moving average is 132.98, which suggests NVO is a Sell.
          What is NVO’s 20-day moving average?
          NVO 20-day moving average is 128.24, which suggests NVO is a Buy.
            What is NVO’s 50-day moving average?
            NVO’s 50-day moving average is 128.03, which suggests NVO is a Buy.
              What is NVO’s 200-day moving average?
              NVO’s 200-day moving average is 108.20, which suggests NVO is a Buy.
                What is NVO’s Williams % R (14)?
                NVO’s Williams % R (14) is -21.48, which suggests NVO is a Buy.
                  What is NVO’s CCI (14)?
                  NVO’s CCI (14) is 92.69, which suggests NVO is a Neutral.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis